{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:29:34Z","timestamp":1793978974335,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.5604\/01.3001.0012.7865","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T06:03:47Z","timestamp":1544767427000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?"],"prefix":"10.1016","volume":"18","author":[{"given":"Marta","family":"Gravito-Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gravito-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Tome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0012.7865_bib0010","first-page":"159","article-title":"Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?","volume":"7","author":"Clin","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.5604\/01.3001.0012.7865_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/1319-3767.33470","article-title":"Fibroscan: a noninvasive test of liver fibrosis assessment.","volume":"13","author":"Al-Ghamdi","year":"2007","journal-title":"Saudi J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7865_bib0020","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7865_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7865_bib0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ebiom.2015.05.018","article-title":"Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease.","volume":"2","author":"Baratta","year":"2015","journal-title":"EBioMedicine"},{"key":"10.5604\/01.3001.0012.7865_bib0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2559.2011.04164.x","article-title":"Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens.","volume":"60","author":"Hulkova","year":"2012","journal-title":"Histopathology"},{"key":"10.5604\/01.3001.0012.7865_bib0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.prp.2003.11.001","article-title":"Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy.","volume":"200","author":"Boldrini","year":"2004","journal-title":"Pathol Res Pract"},{"key":"10.5604\/01.3001.0012.7865_bib0045","doi-asserted-by":"crossref","first-page":"E1134","DOI":"10.3390\/ijms18061134","article-title":"A relative deficiency of lysosomal acid lipase activity characterizes non-alcoholic fatty liver disease.","volume":"18","author":"Tovoli","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.5604\/01.3001.0012.7865_bib0050","doi-asserted-by":"crossref","first-page":"28014","DOI":"10.3390\/ijms161226085","article-title":"Does lysosomial acid lipase reduction play a role in adult non-alcoholic fatty liver disease?","volume":"16","author":"Baratta","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.5604\/01.3001.0012.7865_bib0055","doi-asserted-by":"crossref","first-page":"e0156113","DOI":"10.1371\/journal.pone.0156113","article-title":"Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology.","volume":"11","author":"Vespasiani-Gentilucci","year":"2016","journal-title":"PLOS ONE"},{"key":"10.5604\/01.3001.0012.7865_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.atherosclerosis.2017.03.038","article-title":"Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.","volume":"262","author":"Angelico","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.5604\/01.3001.0012.7865_bib0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOL.0b013e328361f6c6","article-title":"Lysosomal acid lipase A and the hypercholesterolaemic phenotype.","volume":"24","author":"Fouchier","year":"2013","journal-title":"Curr Opin Lipiodol"},{"key":"10.5604\/01.3001.0012.7865_bib0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/ijms17030312","article-title":"Low serum lysosomal acid lipase activity correlates with advanced liver disease.","volume":"17","author":"Shteyer","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.5604\/01.3001.0012.7865_bib0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.dld.2016.04.014","article-title":"Reduced lysosomal acid lipase activity - A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients.","volume":"48","author":"Selvakumar","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.5604\/01.3001.0012.7865_bib0080","doi-asserted-by":"crossref","first-page":"A40","DOI":"10.1136\/archdischild-2013-304107.090","article-title":"A simple screening method for the measurement of lysosomal acid lipase using dried blood spots.","volume":"98","author":"Hamilton","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.5604\/01.3001.0012.7865_bib0085","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/BF01070758","article-title":"Fatty liver: biochemical and clinical considerations.","volume":"20","author":"Hoyumpa AM","year":"1975","journal-title":"Am J Dig Dis"},{"key":"10.5604\/01.3001.0012.7865_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4236\/abc.2011.13008","article-title":"Reliability of enzyme assays in dried blood spots for diagnosis of 4 lysosomal storage disorders.","volume":"1","author":"Ceci","year":"2011","journal-title":"Advances in Biological Chemistry"},{"key":"10.5604\/01.3001.0012.7865_bib0095","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.clinbiochem.2017.02.013","article-title":"Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot.","volume":"50","author":"Vespasiani-Gentilucci","year":"2017","journal-title":"Clin Biochem"},{"key":"10.5604\/01.3001.0012.7865_bib0100","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.V59.3.472.472","article-title":"Identification of primary lysosomes in human megakaryocytes and platelets.","volume":"59","author":"Bentfled-Barker","year":"1982","journal-title":"Blood"},{"key":"10.5604\/01.3001.0012.7865_bib0105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.numecd.2012.05.009","article-title":"Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations.","volume":"23","author":"Muntoni","year":"2013","journal-title":"Nut Metab Cardiovasc Dis"},{"key":"10.5604\/01.3001.0012.7865_bib0110","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism.","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.7865_bib0115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease.","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7865_bib0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14218\/JCTH.2014.00037","article-title":"Nonalcoholic fatty liver disease: Dyslipidemia, risk for cardiovascular complications, and treatment strategy.","volume":"3","author":"Zhang","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"10.5604\/01.3001.0012.7865_bib0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.","volume":"45","author":"Melhem","year":"2006","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7865_bib0130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gutjnl-2011-301400","article-title":"NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.","volume":"61","author":"Gur","year":"2012","journal-title":"Gut"},{"key":"10.5604\/01.3001.0012.7865_bib0135","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.","volume":"218","author":"Asrih","year":"2013","journal-title":"J Endocrinol"},{"key":"10.5604\/01.3001.0012.7865_bib0140","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26327","article-title":"Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.","volume":"58","author":"Scott","year":"2013","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7865_bib0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-2275(20)32070-8","article-title":"Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease.","volume":"41","author":"Lohse","year":"2000","journal-title":"J Lipid Res"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119303096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119303096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:42:47Z","timestamp":1761648167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119303096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1665268119303096"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0012.7865","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0012.7865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}